Takeda Readying To Launch Acid Reflux Med Kapidex Within A Month
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese drug maker looks to dexlansoprazole to help offset loses when Prevacid and anti-diabetic Actos go off patent this year.